Identifying Prognostic Biomarkers Related to m6A Modification and Immune Infiltration in Renal Cell Carcinoma

Background: Renal cell carcinoma (RCC) is the largest category of kidney tumors and usually does not have a good prognosis. N6-methyladenosine(m6A) and immune infiltration have received increased attention because of their great influence on the clinical outcome and prognosis of cancer patients. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Junjie, Li, Peng, Zhang, Huijiang, Wu, Qi, Yang, Dongrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690957/
https://www.ncbi.nlm.nih.gov/pubmed/36360294
http://dx.doi.org/10.3390/genes13112059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690957/
https://www.ncbi.nlm.nih.gov/pubmed/36360294
http://dx.doi.org/10.3390/genes13112059

Ejemplares similares